comparemela.com

Latest Breaking News On - Phase 3 neocol study - Page 1 : comparemela.com

Continued CRC Research Informs Later-Line Disease Management

Howard S. Hochster, MD, highlights key updates in CRC research and management from the 2023 ASCO Annual Meeting, including findings from the phase 2/3 PROSPECT trial, long-term follow-up data from the phase 3 PRODIGE 23 trial, and results of the phase 3 NeoCol study.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.